Impaired cell-mediated immunity among HLA-B27 related rheumatoid variants responding to Yersinia antigen.
D000942:Antigens, Bacterial / Q000276:immunology*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000235:genetics* / Q000276:immunology; D005260:Female; D014644:Genetic Variation; D006680:HLA Antigens / Q000235:genetics* / Q000276:immunology; D015796:HLA-B27 Antigen; D006801:Humans; D007111:Immunity, Cellular; D007075:Immunoglobulin M / Q000096:biosynthesis; D007958:Leukocyte Count; D007961:Leukocyte Migration-Inhibitory Factors / Q000096:biosynthesis / Q000494:pharmacology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D010375:Pedigree; D013167:Spondylitis, Ankylosing / Q000235:genetics / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D015009:Yersinia Infections / Q000150:complications / Q000235:genetics* / Q000276:immunology
D000942:Antigens, Bacterial; D006680:HLA Antigens; D015796:HLA-B27 Antigen; D007075:Immunoglobulin M; D007961:Leukocyte Migration-Inhibitory Factors